1. Home
  2. ONL vs CNTX Comparison

ONL vs CNTX Comparison

Compare ONL & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.26

Market Cap

111.5M

Sector

Real Estate

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

116.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
CNTX
Founded
2021
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.5M
116.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ONL
CNTX
Price
$2.26
$1.14
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
N/A
$5.67
AVG Volume (30 Days)
308.1K
680.8K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
3.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$149,775,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$0.49
52 Week High
$4.25
$1.55

Technical Indicators

Market Signals
Indicator
ONL
CNTX
Relative Strength Index (RSI) 55.79 49.78
Support Level $1.97 $1.08
Resistance Level $2.28 $1.34
Average True Range (ATR) 0.10 0.10
MACD 0.04 0.01
Stochastic Oscillator 93.06 35.90

Price Performance

Historical Comparison
ONL
CNTX

About ONL Orion Office REIT Inc.

Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: